Worse Emotional Health-Related QoL Seen for Women With Cirrhosis, Ascites
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 21, 2025 -- Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue of the American Journal of Gastroenterology.
Florence Wong, M.D., from the University of Toronto, and colleagues examined sex differences in perception of ascites burden and its impact on HRQoL in patients with recurrent or refractory ascites. The study included 392 men and 184 women outpatients with cirrhosis and large ascites requiring repeat large-volume paracenteses.
Similar comorbidities and cirrhosis complications, ascites duration and severity, and frailty scores were seen in both groups. The researchers found that compared with men, women had more symptoms related to their ascites (Ascites Questionnaire score, 66 ± 21 versus 60 ± 21). Feeling depressed was more common for women than men (35 versus 22 percent), and women had lower mental -- but not physical -- functioning components on the Short Form 36. As indicated by the Duke Status Activity Index and Godin Leisure Activity Index, women continued to conduct their daily activities as adequately as men.
"This study underscores the differences in the lived experience of women versus men with cirrhosis and highlights the need for both objective and patient-reported metrics to provide appropriate, patient-centered care for patients with cirrhosis," the authors write. "It is not clear whether a reduced HRQoL in patients with ascites correlates with higher mortality."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis
THURSDAY, July 24, 2025 -- For inpatients with cirrhosis, a machine learning (ML) model using random forest (RF) analysis is superior for prediction of inpatient mortality...
Metabolic Surgery May Be Beneficial in MASH-Related Cirrhosis, Obesity
MONDAY, Feb. 3, 2025 -- For patients with compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and obesity, metabolic surgery is associated with a...
Dose-Dependent Link Seen for Alcohol, Cirrhosis, Liver Cancer in Patients With Hep B
WEDNESDAY, Jan. 29, 2025 -- For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma (HCC)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.